Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 12/20 | 0.66 |
| ▸ | LDHB | P07195 | 11/20 | 0.66 |
| ▸ | ALB | P02768 | 3/20 | 0.66 |
| ▸ | DHODH | Q02127 | 3/20 | 0.44 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29260803 | 0.84 | DHODH (0.55) | LDHALDHBALBDHODHPDE10A | |
| SCHEMBL27745289 | 0.83 | LDHA (0.46) | LDHALDHBALBDHODHPDE10A | |
| SCHEMBL3846362 | 0.83 | LDHA (0.46) | LDHALDHBALBDHODHPDE10A | |
| SCHEMBL29750641 | 0.80 | LDHA (1.00) | LDHALDHBALBDHODH | |
| SCHEMBL426471 | 0.80 | LDHA (1.00) | LDHALDHBALBDHODH | |
| SCHEMBL19202239 | 0.78 | LDHA (0.43) | LDHALDHBALBKDM4EMEN1 | |
| SCHEMBL6450325 | 0.78 | DHODH (0.50) | LDHALDHBALBDHODHPDE10A | |
| SCHEMBL31039922 | 0.78 | DHODH (0.50) | LDHALDHBALBDHODHPDE10A | |
| SCHEMBL19203138 | 0.77 | LDHA (0.66) | LDHALDHBALBDHODHPDE10A | |
| SCHEMBL7173943 | 0.76 | LDHA (1.00) | LDHALDHBALBKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739223-B2 | Surface primer compositions and methods of use | ENVISTA (US) | 2023-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739223-B2 | Surface primer compositions and methods of use | SP1, GPER1, GRIN1 | LDHA 2656/4885LDHB 2298/4885ALB 1999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.